Literature DB >> 22358515

Changes in monoclonal antibody productivity of recombinant BHK cells immobilized in collagen gel particles.

M Yamaguchi1, Y Shirai, Y Inouye, M Shoji, M Kamei, S Hashizume, S Shirahata.   

Abstract

Animal cell perfusion high density culture is often adopted for the production of biologicals in industry. In high density culture sometimes the productivity of biologicals has been found to be enhanced. Especially in immobilized animal cell culture, significant increase in the productivity has been reported. We have found that the specific monoclonal antibody (MAb) productivity of an immobilized hybridoma cell is enhanced more than double. Several examples of enhancing productivities have been also shown by collagen immobilized cells. Immobilized cells involve some different points from non-immobilized cells in high density culture: In immobilized culture, some cells are contacted together, resulting in locally much higher cell concentration more than 10(8) cells/ml. Information originating from a cell can be easily transduced to the others in immobilized culture because the distance between cells is much nearer. Here we have performed collagen gel immobilized culture of recombinant BHK cells which produce a human IgG monoclonal antibody in a protein-free medium for more than three months. In this high density culture a stabilized monoclonal antibody production was found with around 8 times higher specific monoclonal antibody productivity compared with that in a batch serum containing culture. No higher MAb productivity was observed using a conditioned medium which was obtained from the high density culture, indicating that no components secreted from the immobilized cells work for enhancing monoclonal antibody production. The MAb productivity by the non-immobilized cells obtained by dissolving collagen using a collagenase gradually decreased and returned to the original level in the batch culture using a fresh medium. This suggests that the direct contact of the cells or a very close distance between the cells has something to do with the enhancement of the MAb productivity, and the higher productivity is kept for a while in each cell after they are drawn apart.

Entities:  

Year:  1997        PMID: 22358515      PMCID: PMC3449872          DOI: 10.1023/A:1007959400666

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  23 in total

1.  Purification of immunoglobulin production stimulation factor II alpha derived from Namalwa cells.

Authors:  T Sugahara; S Shirahata; K Yamada; H Murakami
Journal:  Cytotechnology       Date:  1991-03       Impact factor: 2.058

2.  Mechanisms and kinetics of monoclonal antibody synthesis and secretion in synchronous and asynchronous hybridoma cell cultures.

Authors:  M al-Rubeai; A N Emery
Journal:  J Biotechnol       Date:  1990-10       Impact factor: 3.307

3.  Batch production and growth kinetics of hybridomas.

Authors:  O W Merten
Journal:  Cytotechnology       Date:  1988-02       Impact factor: 2.058

4.  Hybridoma perfusion systems: a comparison study.

Authors:  D de la Broise; M Noiseux; B Massie; R Lemieux
Journal:  Biotechnol Bioeng       Date:  1992-06-05       Impact factor: 4.530

5.  Phase I trial of multiple large doses of murine monoclonal antibody CO17-1A. II. Pharmacokinetics and immune response.

Authors:  M B Khazaeli; M N Saleh; R H Wheeler; W J Huster; H Holden; R Carrano; A F LoBuglio
Journal:  J Natl Cancer Inst       Date:  1988-08-17       Impact factor: 13.506

6.  Immunoglobulin production stimulating and inhibiting factors derived from human lung adenocarcinoma PC-8 cells : Ig production stimulating factor in PC-8 cells.

Authors:  H Shinmoto; H Murakami; K Yamada; S Dosako; H Omura
Journal:  Cytotechnology       Date:  1988-11       Impact factor: 2.058

7.  Oxygen uptake by entrapped hybridoma cells.

Authors:  D Wohlpart; J Gainer; D Kirwan
Journal:  Biotechnol Bioeng       Date:  1991-05       Impact factor: 4.530

8.  Partial purification and characterization of immunoglobulin production stimulating factor derived from Namalwa cells.

Authors:  K Yamada; K Akiyoshi; H Murakami; T Sugahara; I Ikeda; K Toyoda; H Omura
Journal:  In Vitro Cell Dev Biol       Date:  1989-03

9.  Cell Culture conditions determine the enhancement of specific monoclonal antibody productivity of calcium alginate-entrapped S3H5/gamma2bA2 hybridoma cells.

Authors:  G M Lee; A S Chuck; B O Palsson
Journal:  Biotechnol Bioeng       Date:  1993-02-05       Impact factor: 4.530

10.  Preclinical studies on the pharmacokinetic properties of human monoclonal antibodies to colorectal cancer and their use for detection of tumors.

Authors:  R P McCabe; L C Peters; M V Haspel; N Pomato; J A Carrasquillo; M G Hanna
Journal:  Cancer Res       Date:  1988-08-01       Impact factor: 12.701

View more
  4 in total

1.  Properties of ras-amplified recombinant BHK-21 cells in protein-free culture.

Authors:  Y Inoue; S Kawamoto; M Shoji; S Hashizume; K Teruya; Y Katakura; S Shirahata
Journal:  Cytotechnology       Date:  2000-07       Impact factor: 2.058

2.  Production of interferon-beta by fibroblast cells on membranes prepared by extracellular matrix proteins.

Authors:  Akon Higuchi; Yasunari Takanashi; Takeshi Ohno; Tetsuo Asakura; Chong-Su Cho; Toshihiro Akaike; Mariko Hara
Journal:  Cytotechnology       Date:  2002-09       Impact factor: 2.058

3.  Enhanced production of human recombinant proteins from CHO cells grown to high densities in macroporous microcarriers.

Authors:  T Tharmalingam; K Sunley; M Spearman; M Butler
Journal:  Mol Biotechnol       Date:  2011-11       Impact factor: 2.695

4.  Enhanced CEA production associated with aspirin in a culture of CW-2 cells on some polymeric films.

Authors:  A Higuchi; S Uchiyama; M Demura; T Asakura; C S Cho; T Akaike; H Takarada; M Hara
Journal:  Cytotechnology       Date:  1999-11       Impact factor: 2.058

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.